MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Neurilemmoma

(UMLS:C0027809)

Definition:: A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5)
UMLS ID:: C0027809
MeSH ID:: D009442

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465.625.650.595|C04.557.580.600.610.595|C04.557.580.625.650.595

Synonym(s)

Neurilemmoma

Benign Neurilemmoma

Benign Schwannoma

Neurilemmoma NOS

Neurilemmoma, NOS

Neurilemoma

Neurilemoma NOS

Neurinoma

Neurolemmoma

10.

Psammomatous schwannoma

11.

SCHWANNOMA

12.

SCHWANNOMA, BENIGN

13.

Schwann cell tumor

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Alendronate	FAERS: 7		US FAERS
2	Amlodipine	FAERS: 3		US FAERS
3	Bimatoprost	FAERS: 1		US FAERS
4	Clozapine	FAERS: 1		US FAERS
5	Exenatide	FAERS: 1		US FAERS
6	Pregabalin	FAERS: 1		US FAERS
7	Teriparatide	FAERS: 1		US FAERS
8	Azathioprine			OFFSIDES
9	Carmustine		175631	CTD
10	Enalapril			OFFSIDES
11	Ethylnitrosourea		16003739 16651423 17160924	CTD
12	Hydralazine			OFFSIDES
13	Ifosfamide		2567921	CTD
14	Mannitol			OFFSIDES
15	Methylnitrosourea		11555667	CTD
16	Norethindrone			OFFSIDES
17	NuvaRing			OFFSIDES
18	Sildenafil Citrate			OFFSIDES
19	Tretinoin			OFFSIDES
20	Triazolam			OFFSIDES
21	rilmazafone			OFFSIDES

Similar ADE(s)

	Name	Semantic Similarity
1	melanoma	53.6%
2	Paraganglioma	49.5%
3	Neoplasms, Neuroepithelial	49.1%
4	Gliomatosis cerebri	49.1%
5	Adenoma, Acidophil	48.5%
6	Carcinoid Tumor	46%
7	Craniopharyngioma	44.1%
8	Neuroectodermal Tumor, Melanotic	44.1%
9	Hutchinson's Melanotic Freckle	38.1%
10	Melanoma, Amelanotic	38.1%
11	Pheochromocytoma	37%
12	Melanoma, Experimental	34.5%
13	Malignant Carcinoid Syndrome	34.4%
14	leukemia	33.1%
15	Neoplasms, Glandular and Epithelial	33.1%
16	Ganglioneuroma	31.6%
17	Glioma	31.6%
18	Malignant Glioma	31.6%
19	Meningioma	31.3%
20	Medulloblastoma	30.6%
21	Histiocytic Disorders, Malignant	26.6%
22	Chordoma	26.1%
23	Teratoma	26.1%
24	Germinoma	26.1%
25	Teratocarcinoma	26.1%
26	Neuroectodermal Tumors	25.9%
27	Trophoblastic Neoplasms	25.2%
28	Carcinoid Heart Disease	24.9%
29	Carcinosarcoma	23.2%
30	Hemangiosarcoma	23.2%
31	lymphangiosarcoma	23.2%
32	Astrocytoma	23%
33	Ependymoma	23%
34	oligodendroglioma	23%
35	Ganglioglioma	23%
36	gliosarcoma	23%
37	Anaplastic astrocytoma	23%
38	Anaplastic Oligodendroglioma	23%
39	Lymphoma	22.2%
40	Neoplasms, Germ Cell and Embryonal	22%
41	Germ Cell Cancer	22%
42	Hamartoma	21.5%
43	Neoplasms, Hormone-Dependent	21.5%
44	Neoplasms, Multiple Primary	21.5%
45	Paraneoplastic Syndromes	21.5%
46	Precancerous Conditions	21.5%
47	Neoplasms, Second Primary	21.5%
48	Dermoid Cyst	21.5%
49	Retinoblastoma	20.8%
50	Composite Lymphoma	20.8%
51	neurofibroma	19.9%
52	Leukemia, Experimental	19.6%
53	Carcinoma 256, Walker	19.5%
54	Leukemia, Plasma Cell	19.3%
55	Glioblastoma	18.7%
56	Neuroblastoma	18.7%
57	Glioblastoma Multiforme	18.7%
58	Adenoma	18.1%
59	Ameloblastoma	18.1%
60	Angiokeratoma	18.1%
61	Carcinoma	18.1%
62	Hemangioma	18.1%
63	hemangiopericytoma	18.1%
64	Lymphangioma	18.1%
65	Mesenchymoma	18.1%
66	Nevus	18.1%
67	Hepatoblastoma	18.1%
68	Mixed Tumor, Mullerian	18.1%
69	Angiofibroma	18.1%
70	Sarcoma	18.1%
71	Epithelioma	18.1%
72	Carcinoma, Ehrlich Tumor	17.6%
73	Carcinoma, Lewis Lung	17.6%
74	Cyst	17.4%
75	Neoplastic Processes	17.4%
76	Neoplastic Syndromes, Hereditary	17.4%
77	Pregnancy Complications, Neoplastic	17.4%
78	Basal cell carcinoma	17.3%
79	Carcinoma, Papillary	17.3%
80	Squamous cell carcinoma	17.3%
81	Chondrosarcoma	17.3%
82	Cystadenoma	17.3%
83	leiomyosarcoma	17.3%
84	liposarcoma	17.3%
85	Mesothelioma	17.3%
86	synovial sarcoma	17.3%
87	Angiomyolipoma	17.3%
88	Clear Cell Sarcoma of Soft Tissue	17.3%
89	Alveolar Soft Part Sarcoma	17.3%
90	Sarcoma, Myeloid	17.3%
91	Carcinoma, Basal Cell	17.3%
92	Neoplasms, Experimental	17.2%
93	Leukemia, Radiation-Induced	17%
94	Ganglioneuroblastoma	16.6%
95	Choriocarcinoma	16.5%
96	Neurofibrosarcoma	16.1%
97	Dysgerminoma	15.5%
98	Seminoma	15.5%
99	Neuroendocrine Tumors	15.3%
100	Sarcoma, Experimental	14.6%
101	Plasmacytoma	14.6%
102	Thymoma	14.6%
103	Malignant histiocytosis	14.5%
104	Histiocytic sarcoma	14.5%
105	Multiple Endocrine Neoplasia	14.5%
106	Neoplasms, Radiation-Induced	14.4%
107	Endometrial Stromal Sarcoma	14.3%
108	Cystadenocarcinoma	14.3%
109	Fibrosarcoma	14.3%
110	Osteosarcoma	14.3%
111	Mucoepidermoid Carcinoma	14.3%
112	Carcinoma, Lobular	13.8%
113	Neurilemmoma	13.8%
114	Leukemia L1210	13.5%
115	Leukemia P388	13.5%
116	Acanthoma	13.5%
117	Vipoma	12.9%
118	Adenofibroma	12.9%
119	Fibroadenoma	12.9%
120	Malignant Fibrous Histiocytoma	12.9%
121	Lymphangioleiomyomatosis	12.4%
122	Hodgkin Disease	12.1%
123	Lymphoma, Non-Hodgkin	12.1%
124	Optic Nerve Glioma	12%
125	Neuroma	12%
126	Paraneoplastic Encephalomyelitis	11.6%
127	Nephroblastoma	11.5%
128	Mammary Neoplasms, Experimental	11.4%
129	Bowen's Disease	11.4%
130	Rhabdomyosarcoma	11.4%
131	Giant Cell Tumor of Bone	11.4%
132	Tuberous Sclerosis	11.3%
133	Abdominal Neoplasms	11%
134	Erythroplasia	11%
135	Follicular cyst	11%
136	Head and Neck Neoplasms	11%
137	Mucocele	11%
138	Pilonidal Cyst	11%
139	Soft Tissue Neoplasms	11%
140	Thoracic Neoplasms	11%
141	Thyroglossal Cyst	11%
142	Synovial Cyst	11%
143	Aberrant Crypt Foci	11%
144	Adenocarcinoma	10.8%
145	Carcinoma in Situ	10.8%
146	Carcinoma, Transitional Cell	10.8%
147	Phyllodes Tumor	10.8%
148	Hemangioendothelioma	10.8%
149	Lipoma	10.8%
150	Myoma	10.8%
151	Myxoma	10.8%
152	Papilloma	10.8%
153	Pseudomyxoma Peritonei	10.8%
154	Papillomatosis	10.8%
155	Angiolipoma	10.8%
156	Myelolipoma	10.8%
157	Neoplasms, Bone Tissue	10.8%
158	Neoplasms, Fibrous Tissue	10.8%
159	Smooth Muscle Tumor	10.8%
160	Adenomatosis, Pulmonary	10.8%
161	Adenomatous Polyps	10.8%
162	Carcinoma, Large Cell	10.8%
163	Carcinoma, Small Cell	10.8%
164	Desmoplastic Small Round Cell Tumor	10.8%
165	Chondroma	10.8%
166	Enchondroma	10.8%
167	Sarcoma 180	10.6%
168	Primary amyloidosis	10.4%
169	Lymphomatoid Granulomatosis	10.3%
170	Dermatofibrosarcoma	10%
171	Dermatofibrosarcoma Protuberans	10%
172	Basal Cell Nevus Syndrome	9.3%
173	Hydatidiform Mole	9.3%
174	Digestive System Neoplasms	9.2%
175	Endocrine Gland Neoplasms	9.2%
176	Eye Neoplasms	9.2%
177	Nervous System Neoplasms	9.2%
178	Mesoblastic Nephroma	9.1%
179	Bone neoplasms	9%
180	Leukoplakia	9%
181	Lymphocele	9%
182	Pancreatic Cyst	9%
183	Skin Neoplasms	9%
184	Hematologic Neoplasms	9%
185	Barrett Esophagus	8.9%
186	Breast Cyst	8.9%
187	Actinic keratosis	8.9%
188	Mediastinal Cyst	8.9%
189	Neoplasm Invasiveness	8.9%
190	Neoplasm Metastasis	8.9%
191	Neoplasm Recurrence, Local	8.9%
192	Parovarian Cyst	8.9%
193	Pericardial Cyst	8.9%
194	Splenic Neoplasms	8.9%
195	Thymic Cyst	8.9%
196	Carcinogenesis	8.9%
197	Myxoid cyst	8.9%
198	Metastasis	8.9%
199	Leukemia, Myelomonocytic, Chronic	8.6%
200	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	8.6%
201	Alveolar rhabdomyosarcoma	8.5%
202	Hepatocellular Adenoma	8.3%
203	Waldenstrom Macroglobulinemia	8.1%
204	Multiple Myeloma	8.1%
205	Carcinoma, Pancreatic Ductal	8%
206	Multiple Endocrine Neoplasia Type 1	7.9%
207	Liver Neoplasms, Experimental	7.4%
208	Mastocytosis	7.4%
209	Sturge-Weber Syndrome	7.4%
210	Corpus Luteum Cyst	7.3%
211	Ovarian Cysts	7.3%
212	Gastrointestinal Stromal Tumors	7.3%
213	Acoustic Neuroma	7.3%
214	Prolactinoma	7.3%
215	Growth Hormone-Secreting Pituitary Adenoma	7.3%
216	Hemangioma, Cavernous	7.2%
217	Leukemia, T-Cell	7.2%
218	Leukemia, B-Cell	7.2%
219	Lymphoma, Follicular	7.2%
220	T-Cell Lymphoma	7.2%
221	Mantle cell lymphoma	7.2%
222	Adenoid Cystic Carcinoma	7.1%
223	fibroma	7.1%
224	Fibromatosis	7.1%
225	Osteoblastoma	7.1%
226	Osteoma	7.1%
227	Rhabdomyoma	7.1%
228	Chondromatosis	7.1%
229	Adenocarcinoma, Clear Cell	7.1%
230	Cholangiocarcinoma	7.1%
231	Cervical Intraepithelial Neoplasia	7.1%
232	Hemangioblastoma	7.1%
233	Lymphoma, Extranodal NK-T-Cell	7.1%
234	Parathyroid Neoplasms	7.1%
235	Peritoneal Neoplasms	7.1%
236	Thyroid Neoplasm	7.1%
237	Thyroid carcinoma	7.1%
238	Adenomatous Polyposis Coli	6.6%
239	Choledochal Cyst	6.4%
240	granulosa cell tumor	6.4%
241	Carcinoma, Ovarian Epithelial	6.4%
242	Pancreatic Neoplasm	6.3%
243	Peutz-Jeghers Syndrome	6.3%
244	Retroperitoneal Neoplasms	6%
245	Mastocytoma	5.8%
246	Mastocytosis, Systemic	5.7%
247	Leukemia, Myeloid, Chronic-Phase	5.7%
248	Tracheal Neoplasms	5.7%
249	Leukoplakia, Oral	5.6%
250	Paraneoplastic Cerebellar Degeneration	5.5%
251	Fibromatosis, Aggressive	5.3%
252	Fibromatosis, Abdominal	5.3%
253	Klatskin Tumor	5.3%
254	insulinoma	5.3%
255	Nasopharyngeal carcinoma	5%
256	Denys-Drash Syndrome	4.9%
257	Mouth Neoplasms	4.9%
258	Central Nervous System Neoplasms	4.9%
259	Vascular Neoplasms	4.9%
260	Thymus Neoplasms	4.9%
261	Esophageal Neoplasms	4.9%
262	Genital Neoplasms, Female	4.9%
263	Pancreatic Pseudocyst	4.9%
264	Limbic Encephalitis	4.8%
265	Lymphatic Metastasis	4.8%
266	Neoplasms, Unknown Primary	4.8%
267	Leukemic Infiltration	4.8%
268	Breast Neoplasms, Male	4.8%
269	Neoplasm Micrometastasis	4.8%
270	Triple Negative Breast Neoplasms	4.8%
271	Adrenocortical carcinoma	4.8%
272	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	4.8%
273	Leukemia, Large Granular Lymphocytic	4.8%
274	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	4.8%
275	Lymphoma, T-Cell, Cutaneous	4.7%
276	Lymphoma, AIDS-Related	4.7%
277	Enteropathy-Associated T-Cell Lymphoma	4.7%
278	Primary Effusion Lymphoma	4.7%
279	Leydig Cell Tumor	4.5%
280	Gastrinoma	4.5%
281	Glucagonoma	4.5%
282	Lambert-Eaton Myasthenic Syndrome	4.4%
283	Testicular Neoplasms	4.4%
284	Renal Cell Carcinoma	4.2%
285	Papillary Renal Cell Carcinoma	4.2%
286	Thyroid Nodule	4.2%
287	Adrenal Gland Neoplasms	4.2%
288	Gastrointestinal Neoplasms	4.2%
289	Genital Neoplasms, Male	4.2%
290	Liver neoplasms	4.2%
291	Uveal Neoplasms	4.2%
292	Urologic Neoplasms	4.1%
293	Sebaceous Gland Neoplasms	4.1%
294	Spinal Neoplasms	4.1%
295	Bone Marrow Neoplasms	4.1%
296	Xeroderma Pigmentosum	4.1%
297	Polycystic Ovary Syndrome	4%
298	Carcinoma, Endometrioid	4%
299	Opsoclonus-Myoclonus Syndrome	3.9%
300	Dupuytren Contracture	3.7%
301	Urticaria Pigmentosa	3.6%
302	Burkitt Lymphoma	3.6%
303	Mycosis Fungoides	3.6%
304	Lymphomatoid Papulosis	3.6%
305	Plasmablastic lymphoma	3.6%
306	Myelitis, Transverse	3.5%
307	ovarian neoplasm	3.1%
308	Nose Neoplasms	3%
309	Meningeal Neoplasms	2.9%
310	Pituitary Adenoma	2.8%
311	Pituitary Neoplasms	2.8%
312	Sezary Syndrome	2.7%
313	Palatal Neoplasms	2.7%
314	Ear Neoplasms	2.5%
315	Eyelid Neoplasms	2.5%
316	Lung Neoplasms	2.5%
317	Pleural Neoplasms	2.5%
318	Zollinger-Ellison syndrome	2.4%
319	Cell Transformation, Viral	2.4%
320	Brain Neoplasms	2.4%
321	Salivary Gland Neoplasms	2.4%
322	Spinal Cord Neoplasms	2.4%
323	Tongue Neoplasms	2.4%
324	Uterine Neoplasms	2.4%
325	Vaginal Neoplasms	2.4%
326	Vulvar Neoplasms	2.4%
327	Uterine Cancer	2.4%
328	Fallopian Tube Neoplasms	2.4%
329	Pharyngeal Neoplasms	2.1%
330	Central Nervous System Cysts	2.1%
331	Bile Duct Neoplasms	2.1%
332	gallbladder neoplasm	2.1%
333	Intestinal Neoplasms	2.1%
334	Penile Neoplasms	2.1%
335	Prostatic Neoplasms	2.1%
336	Stomach Neoplasms	2.1%
337	Polycythemia Vera	2.1%
338	Meningeal Carcinomatosis	1.9%
339	Laryngeal neoplasm	1.9%
340	Bladder Neoplasm	1.8%
341	Kidney Neoplasm	1.8%
342	Ureteral Neoplasms	1.8%
343	Urethral Neoplasms	1.8%
344	Bronchial Neoplasms	1.6%
345	Multiple Pulmonary Nodules	1.6%
346	Supratentorial Neoplasms	1.6%
347	Endometrial Neoplasms	1.6%
348	Hypopharyngeal Neoplasms	1.4%
349	Pleural Effusion, Malignant	1.4%
350	Hypopharyngeal Cancer	1.4%
351	Parotid Neoplasms	1.4%
352	Prostatic Neoplasms, Castration-Resistant	1.4%
353	Nelson Syndrome	1.4%
354	Cecal Neoplasms	1.2%
355	Duodenal Neoplasms	1.2%
356	Brain Stem Neoplasms	1.2%
357	Nasopharyngeal Neoplasms	1.1%
358	Colorectal Neoplasms	1.1%
359	Tonsillar Neoplasms	1%
360	Cerebellar Neoplasms	1%
361	Choroid Plexus Papilloma	1%
362	Paranasal Sinus Neoplasms	1%
363	Radicular Cyst	0.9%
364	Appendiceal Neoplasms	0.9%
365	Colonic Neoplasms	0.9%
366	Rectal Neoplasms	0.9%
367	Maxillary Sinus Neoplasms	0.7%
368	Anus Neoplasms	0.7%
369	Sigmoid Neoplasms	0.7%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234